期刊
JOURNAL OF BIOPHARMACEUTICAL STATISTICS
卷 22, 期 4, 页码 719-736出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/10543406.2012.676535
关键词
Adaptive designs; Delayed response; Optimal allocation; Sequential analysis
资金
- National Science Foundation (USA) [DMS-0907297, DMS-0906661]
- National Science Foundation [DMS-0904253]
- Direct For Mathematical & Physical Scien
- Division Of Mathematical Sciences [0907297] Funding Source: National Science Foundation
In February 2010, the U.S. Food and Drug Administration (FDA, 2010) drafted guidance that discusses the statistical, clinical, and regulatory aspects of various adaptive designs for clinical trials. An important class of adaptive designs is adaptive randomization, which is considered very briefly in subsection VI.B of the guidance. The objective of this paper is to review several important new classes of adaptive randomization procedures and convey information on the recent developments in the literature on this topic. Much of this literature has been focused on the development of methodology to address past criticisms and concerns that have hindered the broader use of adaptive randomization. We conclude that adaptive randomization is a very broad area of experimental design that has important application in modern clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据